{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "8984600",
  "DateCompleted": {
    "Year": "1997",
    "Month": "01",
    "Day": "09"
  },
  "DateRevised": {
    "Year": "2013",
    "Month": "11",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "ger"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0036-7672",
      "JournalIssue": {
        "Volume": "126",
        "Issue": "44",
        "PubDate": {
          "Year": "1996",
          "Month": "Nov",
          "Day": "02"
        }
      },
      "Title": "Schweizerische medizinische Wochenschrift",
      "ISOAbbreviation": "Schweiz Med Wochenschr"
    },
    "ArticleTitle": "[Decongestant nasal spray. Results of a rhinomanometric double-blind study].",
    "Pagination": {
      "StartPage": "1875",
      "EndPage": "1880",
      "MedlinePgn": "1875-80"
    },
    "Abstract": {
      "AbstractText": [
        "Between november 1993 and july 1995 60 patients with a common cold underwent randomized and double-blind testing of 3 commercial nasal sprays-benzydamine, xylometazoline combined with the secretolytic S-carboxymethylcysteine, and phenylephrine combined with the antihistaminic dimethindene maleate. After prior active rhinomanometric measurement of the untreated nose, the test substance was applied. The change of nasal patency was registered after 3 and 10 minutes and then after 2, 4, 6 and 8 hours. At the end the patient gave a subjective evaluation of the used spray. There was no change in nasal obstruction following application of NaCl or benzydamine. Xylometazoline/S-carboxymethylcysteine (+87%) or phenylephrine/ dimethindene maleate (+113%) augmented nasal patency within minutes. Using phenylephrine/dimethindene maleate the effect lasted less than 2 hours, while after xylometazoline/S-carboxymethylcysteine decongestion lasted more than 6 hours. The patients also subjectively reported an increase in nasal patency after the use of benzydamine and placebo. But only phenylephrine/ dimethindene maleate or xylometazoline/S-carboxymethylcysteine were judged good. Using benzydamine or phenylephrine + dimethindene maleate, more side-effects (mainly dryness and burning) were mentioned. Considering the subjective assessment of side-effects and duration of action, as well as objective parameters, derivatives of imidazole (oxymetazoline and xylometazoline) are first choice in treatment of the common cold."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "HNO-Klinik, Kantonsspital Aarau."
          }
        ],
        "LastName": "Maranta",
        "ForeName": "C A",
        "Initials": "CA"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Simmen",
        "ForeName": "D",
        "Initials": "D"
      }
    ],
    "PublicationTypeList": [
      "Clinical Trial",
      "Comparative Study",
      "English Abstract",
      "Journal Article",
      "Randomized Controlled Trial"
    ],
    "VernacularTitle": "Abschwellende Nasensprays. Ergebnisse einer rhinomanometrisch objektivierten, doppelblind durchgef\u00fchrten Studie."
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Schweiz Med Wochenschr",
    "NlmUniqueID": "0404401",
    "ISSNLinking": "0036-7672"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Infective Agents, Local"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Histamine H1 Antagonists"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Imidazoles"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Nasal Decongestants"
    },
    {
      "RegistryNumber": "1WS297W6MV",
      "NameOfSubstance": "Phenylephrine"
    },
    {
      "RegistryNumber": "661FH77Z3P",
      "NameOfSubstance": "Dimethindene"
    },
    {
      "RegistryNumber": "740J2QX53R",
      "NameOfSubstance": "Carbocysteine"
    },
    {
      "RegistryNumber": "WPY40FTH8K",
      "NameOfSubstance": "xylometazoline"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Schweiz Med Wochenschr 1996 Nov 30;126(48):2104"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Administration, Intranasal"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Airway Resistance"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Anti-Infective Agents, Local"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Carbocysteine"
    },
    {
      "QualifierName": [
        "drug therapy",
        "physiopathology"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Dimethindene"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Double-Blind Method"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Therapy, Combination"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Histamine H1 Antagonists"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Imidazoles"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Manometry"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "administration & dosage",
        "therapeutic use"
      ],
      "DescriptorName": "Nasal Decongestants"
    },
    {
      "QualifierName": [
        "physiopathology"
      ],
      "DescriptorName": "Nose"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Phenylephrine"
    }
  ]
}